Swedish Orphan Biovitrum (Sobi) is a global leader in providing innovative treatments for people with rare diseases, with a strong commitment to patient access and care. With a focus on Haematology, Immunology, and Specialty Care, Sobi's pipeline of key medicines aims to transform the lives of individuals affected by rare and debilitating conditions.
Through sustainable practices and a dedication to patient-centricity, Sobi works tirelessly to bring new therapies to those in need, emphasizing the importance of access to treatment and humanitarian aid. With a mission to improve the lives of millions worldwide, Sobi's innovative treatments and commitment to societal contribution set them apart in the field of rare disease management.
Generated from the website